Tim Richardson
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Non-ICANS neurotoxicity after BCMA-directed CAR-T therapy: Clinical spectrum, outcomes, and a framework for neurology-oncology co-management.
Journal: HemaSphere
Published: March 15, 2026
Effectiveness of an on-site vaccination campaign for patients with cancer.
Journal: BMC public health
Published: March 05, 2026
Real-world prevalence and prognostic significance of hepatotoxicity after chimeric antigen receptor T-cell therapy.
Journal: British journal of haematology
Published: February 13, 2026
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantation.
Journal: Leukemia research
Published: January 09, 2026
IPSS-M downstaging before transplantation does not improve the prognosis of patients with myelodysplastic neoplasms.
Journal: Bone marrow transplantation
Published: December 06, 2025
Navigating the Post-BCMA/GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta-Refractory Multiple Myeloma-A Multicenter Analysis.
Journal: American journal of hematology
Published: December 02, 2025
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.
Journal: The Lancet. Oncology
Published: October 21, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T Cells.
Journal: EJHaem
Published: July 16, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.
Journal: European journal of haematology
Published: July 07, 2025
Last Updated: 09/26/2026